Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India

被引：0
|
作者：
Bagal, Bhausaheb [1 ]
Mandal, Tanmoy [1 ]
Bonda, Avinash [1 ]
Punatar, Sachin [1 ]
Gokarn, Anant [1 ]
Tembhare, Prashant [1 ]
Jain, Hasmukh [1 ]
Patkar, Nikhil [1 ]
Epari, Sridhar [1 ]
Sengar, Manju [1 ]
Khattry, Navin [1 ]
Shet, Tanuja [1 ]
Gujral, Sumit [1 ]
Banavali, Shripad [1 ]
机构：
[1] Tata Mem Hosp, Bombay, Maharashtra, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Splenic marginal zone lymphoma; Splenectomy; Rituximab;
D O I：
10.1016/j.clml.2018.07.216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NHL-185
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 40 条
  • [21] A Case Report of Conjunctival Extranodal Marginal Zone Lymphoma Treated with Intralesional Rituximab Injection Therapy
    Yazicioglu, Titap
    Oklar, Murat
    Kocabas, Seyhan
    Karadag, Erdi
    Elibol, Vildan
    Tezcan, Mehmet Engin
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (06) : 1329 - 1333
  • [22] Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: A case report
    Kakinoki, Y
    Kubota, H
    Sakurai, H
    Sato, T
    Tokusashi, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (05) : 417 - 420
  • [23] Blastic Transformation after Splenectomy in a Patient with Nonvillous Splenic Marginal Zone Lymphoma with p53 Overexpression: A Case Report
    Yasutaka Kakinoki
    Hiroya Kubota
    Hiroharu Sakurai
    Teiko Sato
    Yoshihiko Tokusashi
    International Journal of Hematology, 2005, 81 : 417 - 420
  • [24] Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center
    de Padua Covas Lage, Luis Alberto
    Caboclo dos Santos, Felipe Faganelli
    Levy, Debora
    Moreira, Frederico Rafael
    Freitas Couto, Samuel Campanelli
    Culler, Hebert Fabricio
    Costa, Renata de Oliveira
    Rocha, Vanderson
    Pereira, Juliana
    BMC CANCER, 2020, 20 (01)
  • [25] Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center
    Luís Alberto de Pádua Covas Lage
    Felipe Faganelli Caboclo dos Santos
    Débora Levy
    Frederico Rafael Moreira
    Samuel Campanelli Freitas Couto
    Hebert Fabrício Culler
    Renata de Oliveira Costa
    Vanderson Rocha
    Juliana Pereira
    BMC Cancer, 20
  • [26] Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report
    Vinholt, Pernille J.
    Nybo, Mads
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (04) : 454 - 457
  • [27] Splenic marginal zone cell lymphoma involving liver and bone marrow. Report of a case with protracted follow-up showing progressive disappearance of the lymphoma after splenectomy
    Rosso, R
    Castello, A
    Colosini, G
    Astori, C
    Lazzarino, M
    Magrini, U
    HAEMATOLOGICA, 1996, 81 (01) : 44 - 46
  • [28] Clinical Course and Outcomes of COVID-19 Infection in Patients Treated with Rituximab: A Tertiary Care Center Experience 
    Alhowaish, Thamer S.
    Alhamadh, Moustafa S.
    Mathkour, Alaa
    Alamoudi, Marwan
    Alqahtani, Hossam Ali
    Alrashid, Abdulrahman
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2023, 15 : 145 - 159
  • [29] Solitary Splenic Metastasis from Ovarian Cancer Successfully Treated by Hand-Assisted Laparoscopic Splenectomy: Report of a Case
    Hiroshi Yano
    Takashi Iwazawa
    Masakatsu Kinuta
    Yoshiaki Nakano
    Takeshi Tono
    Shigeo Matsui
    Toshiyuki Kanoh
    Takushi Monden
    Surgery Today, 2002, 32 : 750 - 752
  • [30] Solitary splenic metastasis from ovarian cancer successfully treated by hand-assisted laparoscopic splenectomy: Report of a case
    Yano, H
    Iwazawa, T
    Kinuta, M
    Nakano, Y
    Tono, T
    Matsui, S
    Kanoh, T
    Monden, T
    SURGERY TODAY, 2002, 32 (08) : 750 - 752
1234